Skip to main content
Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
65.90
+0.96 (1.48%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Solventum Revenue

In the year 2024, Solventum had annual revenue of $8.25B with 0.70% growth. Solventum had revenue of $2.08B in the quarter ending December 31, 2024, with 1.92% growth.

Revenue (ttm)
$8.25B
Revenue Growth
+0.70%
P/S Ratio
1.38
Revenue / Employee
$375,182
Employees
22,000
Market Cap
11.40B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.25B57.00M0.70%
Dec 31, 20238.20B67.00M0.82%
Dec 31, 20228.13B-41.00M-0.50%
Dec 31, 20218.17B890.00M12.22%
Dec 31, 20207.28B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

SOLV News

More News